Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alector Completes Enrollment In PROGRESS-AD Phase 2 Clinical Trial If AL101/GSK4527226 For Individuals With Early Alzheimer's Disease

Author: Benzinga Newsdesk | April 17, 2025 08:08am

Posted In: ALEC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist